Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis, Membranous

Explore clinical trials studying Glomerulonephritis, Membranous. Study availability and eligibility vary by location and protocol.

71 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Glomerulonephritis, Membranous trial results

Completed

MOR202 for Refractory MN

NCT04893096

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • ASST HPG23 - Unità di Nefrologia Bergamo, BG, Italy
  • Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Daccò" Ranica, BG, Italy
View Trial Details
Completed

Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy

NCT01282073

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Dong-A University Medical Center Busan, South Korea
  • Inje University Haeundae Paik Hospital Busan, South Korea
  • Kyungpook National University Hospital Daegu, South Korea
  • Daegu Fatima Hospital Daegu, South Korea
View Trial Details
Completed

Personalized Medicine for Membranous Nephropathy

NCT03804359

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations
  • CHU D'amiens Hôpital Sud Amiens, France
  • CHU Besançon Besançon, France
  • Hôpital universitaire La Cavale Blanche Brest, France
  • CHU de Caen Caen, France
View all 19 locations
View Trial Details
Completed

Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)

NCT04145440

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • North America Research Institute Azusa, California, United States
  • UCSF Medical Center San Francisco, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Torrance, California, United States
  • University of Miami Division of Nephrology & Hypertension Miami, Florida, United States
View all 45 locations
View Trial Details
Completed

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

NCT03453619

Conditions
Autoimmune Diseases, C3 Glomerulonephritis, Connective Tissue Diseases, +18 more
Locations
  • Stanford University Stanford, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • HealthONE Physician Care, Rocky Mountain Hospital for Children Denver, Colorado, United States
  • Washington Nephrology Associates Washington D.C., District of Columbia, United States
View all 17 locations
View Trial Details

Related conditions